Effect of Countermeasures on Nocturnal Driving Performance
NCT01070004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2012-06-14
Summary
Sleep deprivation induces degradation of night-time driving ability via sleepiness. Because of conflicts between physiological needs and social or professional activities, it is necessary to develop affordable countermeasure to sleepiness. In real-life driving studies, nap and coffee are efficient countermeasures of sleepiness at the wheel. However the effect of caffeine is quick but brief and varies between individuals. There is a need for more knowledge in order to know what to recommend to drivers. Exposure to 460-nm monochromatic light (blue light) decreases subjective sleepiness and improves performances. One objective of this project is to investigate whether blue light exposure during driving would be useful in a real driving situation when sleepiness becomes acute. Owing to the fact that our knowledge of the effects of exercise on driving is very sparse and to the absolutely need to standardize the bouts of exercise that will be applied to the subjects. One objective of the present study will be to investigate in a simulator study the effects of a bout of moderate exercise on participants driving ability when sleepiness becomes acute. Nocturnal neurobehavioral performance varies widely between individuals and only certain subjects seem significantly affected by sleep loss. It is of interest to find biological markers for sleep drive to identify vulnerable drivers to sleep deprivation or to identify responders to sleepiness countermeasures (i.e., coffee and blue light). One objective of this study is to determine individual differences (genetic, hormonal and cognitive) in the impairment of driving skills induced by sleep loss and in the efficiency of countermeasures (blue light and coffee).
Conditions
- Sleepiness
Interventions
- OTHER
-
Real driving situation
Continuous blue light exposure during driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time real driving situation. Inside this arm, each volunteer will be randomly allocated and will all receive : continuous blue light exposure, coffee and coffee placebo at each driving session with at least 1 week between each condition.
- OTHER
-
Driving simulator
15 minutes of physical activity at a low intensity before driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time driving simulator. Inside this arm, each volunteer will be randomly allocated and will all receive : 15 minutes of physical activity, coffee and coffee placebo at each driving session with at least 1 week between each condition.
Sponsors & Collaborators
-
ERANET
collaborator UNKNOWN -
INSERM ERI27 Mobilités Cognition et Temporalité
collaborator UNKNOWN -
Hotel Dieu Hospital
collaborator OTHER -
IMF, CNRS UMR-5231
collaborator UNKNOWN -
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Pierre Philip, Pr · University Hospital, Bordeaux
-
Pierre Denise, Pr · INSERM ERI27
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- France
Study Locations
More Related Trials
-
Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers
NCT00368160 ·Status: COMPLETED ·Phase: PHASE1
-
Ramelteon for a Nap Prior to a Night Shift
NCT00595075 ·Status: COMPLETED ·Phase: NA
-
Effect of Armodafinil on Simulated Driving
NCT02468856 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability
NCT00368056 ·Status: COMPLETED ·Phase: PHASE3
-
Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
NCT00688142 ·Status: COMPLETED
-
The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia
NCT00124384 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Ramelteon on Transient Insomnia in Healthy Adults
NCT00671398 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Rozerem on Sleep Among People With Traumatic Brain Injury
NCT01207050 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
NCT00893789 ·Status: TERMINATED ·Phase: PHASE3
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT05838430 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Ramelteon on Driving Ability
NCT00319215 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects
NCT04696952 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder
NCT00758498 ·Status: COMPLETED ·Phase: PHASE3
-
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
NCT02180048 ·Status: COMPLETED ·Phase: NA
-
The Effect of Caffeine on the Narcoleptic Patients
NCT02832336 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Use of Amber Glasses in Improving Sleep
NCT04751019 ·Status: COMPLETED ·Phase: NA
-
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
NCT00280436 ·Status: COMPLETED ·Phase: PHASE2
-
Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia
NCT05289518 ·Status: UNKNOWN ·Phase: NA
-
Performance Evaluation of the Dreem 3 System for Sleep Assessment in Patients With Insomnia
NCT05438017 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.
NCT00671294 ·Status: COMPLETED ·Phase: PHASE3
-
Modulation of Sleep Perception Through Auditory Closed-loop Stimulation of Brain Oscillatory Activity
NCT04276064 ·Status: COMPLETED ·Phase: NA
-
Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance
NCT02080715 ·Status: COMPLETED ·Phase: PHASE1
-
Memory Consolidation in Pharmacologically Enhanced Naps
NCT00777829 ·Status: COMPLETED ·Phase: NA
-
A Study of LY2624803 in Japanese Participants With Transient Insomnia
NCT01784614 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy
NCT03748979 ·Status: COMPLETED ·Phase: PHASE1